Parker, Waichman, Alonso LLP

Home » Topics » Defective Drugs » Cordarone

Injured By Cordarone?

The FDA approved Cordarone on December 18, 1995. Cordarone is another brand name for Amiodarone. These heart drugs continue to be prescribed to millions of patients nationwide without the detailed consumer warnings promised by the U.S. FDA.

Each bottle of the drug, is supposed to include a new advisory that warns of its many risks and symptoms of fatal side effects and explain how the medication is supposed to be used. But the advisory, planned since October 2003, remains in draft form, bouncing back and forth between the FDA and the drug maker assigned to write it.

Sen. Charles Grassley, chairman of the Senate Finance Committee, said he would be looking into the delays in the Amiodarone and Cordarone warnings. "What's happening with this drug goes to the heart of questions about how long it takes the FDA to act when known risks or dangers exist," said Grassley, R-Iowa. "The FDA and drug companies might know about risks, but it doesn't do any good if doctors and patients don't know about them too."

Patients taking Amiodarone and Cordarone have died from lung and liver damage, gone blind or suffered from other serious side effects. Yet these medicines are routinely prescribed for common heart rhythm problems despite the availability of safer alternatives. The FDA has approved Amiodarone only for more severe disorders, called ventricular arrhythmia's, and then only as a treatment of last resort.

Cordarone has recently been linked to Toxic Epidermal Necrolysis (TEN). Toxic Epidermal Necrolysis (TEN) is a rare condition that causes large portions of the epidermis, the skin's outermost layer, to disengage from the layers of skin below. The main cause of Toxic Epidermal Necrolysis (TEN) is from a severe drug reaction.

If you or a loved one took Cordarone and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.